NIH 3T3 cells transfected with basic fibroblast growth factor (bFGF) fused to an immunoglobulin signal peptide sequence are transformed in vitro and tumorigenic in vivo. The transformed phenotype of chimeric signal peptidebFGF (spbFGF) cells is characterized. by an enhanced proliferation rate compared to parental NIl 3T3 cells, density-and anchorage-independent growth, a transformed morphology, and lack of cell adhesion. The rate of spbFGF cell proliferation is not diminished by anti-bFGF neutralizing antibodies. 125I-labeled bFGF receptor cross-linking and binding studies suggest that surface FGF receptors in spbFGF cells are unavailable and down-regulated. The FGF receptors are also down-regulated in K-fgf-transformed cells but not in parental 3T3, native bFGF-transfected, and ras-transformed NIH 3T3 cells. The addition of suramin to spbFGF and K-fgf cells rapidly promotes the up-regulation of FGF receptors. Suramin also induces lowering of the proliferation rate to that of parental cells, anchorage-dependent growth, assembly of cytoskeletal filaments, cellular adhesion, and spreading. These results suggest that spbFGF cells undergo autocrine transformation, possibly by an internal autocrine loop, in which there is constitutive activation of the FGF receptor. Suramin inhibits autocrine transformation, leading to a normal untransformed phenotype.
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Autonomous cell growth and tumorigenicity may result from a constitutive interaction of cellular growth factors with their corresponding receptors (1) . Autocrine transformation occurs either when growth factors are secreted and bind to cell surface receptors to form an external autocrine loop or when they interact with their receptors along the secretory pathway to form an internal autocrine loop (2) . Both external and internal autocrine stimulation requires the presence of a hydrophobic signal peptide that allows the transforming growth factor to gain access to and to interact with its receptor. Recent observations suggest that internal autocrine stimulation is a major mode of malignant transformation (3, 4) . The intracellular site ofgrowth factor-receptor interaction and its relevance to the mechanism of autocrine transforma- tion have not yet been ascertained.
Fibroblast growth factors (FGFs) constitute a family of potent growth and angiogenic factors abundant in normal and malignantly transformed cells (5) (6) (7) . Unlike most other polypeptide growth factors, basic fibroblast growth factor (bFGF) and acidic fibroblast growth factor (aFGF) are not secreted but are mainly cell-associated, consistent with their lack of signal peptide sequences. The biological activity of FGF is mediated through specific high-affinity saturable cell surface receptors (8, 9) . Most if not all cells possess FGF receptors, which are phosphorylated and internalized upon binding of FGF. A 130-kDa high-affinity FGF receptor containing an intracellular tyrosine kinase domain has been purified and cloned (10) (11) (12) . A low-affinity large-capacity class of binding sites for FGF has also been identified. These are cell surface and extracellular matrix heparan sulfate proteoglycans, which constitute a major pool of cell-associated FGF (21) . Despite the abundance of FGF in cells and extracellular matrix in vitro (13) and in vivo (14) , cells with available functional FGF receptors are not transformed.
The oncogenes, int-2 and hst/K-fgf, and the FGF-5 gene, have been identified and shown to have a 40-45% homology to bFGF and aFGF (15) (16) (17) . These oncogenes encode proteins that possess an amino-terminal signal peptide sequence and are secreted. The transforming potential in vitro and the occurrence of these oncogenes in tumors and in the developing embryo suggest that these FGF-related oncogenes may be involved in autocrine transformation. Possession of a signal peptide sequence, therefore, appears to be an important factor in determining the transforming potential of members ofthe FGF family. The bFGF gene can be converted into an oncogene by addition of a 19-amino acid immunoglobulin signal peptide sequence (18) . NIH 3T3 cells transfected with this chimeric signal peptide-bFGF (spbFGF) sequence express bFGF and are highly transformed in vitro and tumorigenic in vivo. In this report we present evidence that spbFGF but After 24 hr, the medium was replaced with either fresh medium alone or fresh medium containing 0.4 mM suramin for an additional 24 hr. The cells were fixed with 4% (wt/vol) formaldehyde/isotonic phosphate-buffered saline (PBS) for 1 hr at room temperature, washed three times with PBS, and permeabilized with 0.2% Triton X-100/0.1% bovine serum albumin (BSA: fraction V, Sigma)/PBS for 15 min at room temperature. Rhodamine-labeled phalloidin (Molecular Probes, Junction City, OR) was added at a 1:1000 dilution for 1 hr at room temperature. The cells were washed three times with PBS, mounted with glycerol, examined with a phasecontrast epifluoresence microscope (Zeiss) and photographed with Kodak Tri-X film.
High-Affinity Binding of 1251-bFGF. Confluent cultures (1 x 106 cells per 35-mm dish) were incubated alone or with 0.4 mM suramin for 48 hr and were washed three times with ice-cold PBS and once with BSA (2 mg/ml)/PBS. Cells were incubated for 2 hr at 4°C in DMEM containing BSA (2 mg/ ml), 1 mM MgCl2, and saturating concentrations of 1251-bFGF (10 ng/ml, 150 ,uCi/,g). The cells were washed once with ice-cold PBS/heparin (10 ,g/ml)/BSA (2 mg/ml)/0.1 ,M KI/1 mM MgCl2 and once with ice-cold PBS. Heparin and KI were included in the buffer to reduce nonspecific and lowaffinity binding (13) . The cells were then lysed in PBS containing 1% Triton X-100, and cell-associated radioactivity was determined in a y counter (Beckman, Gamma 5500). Non-specific binding was determined by including a 200-fold excess of unlabeled bFGF in the binding buffer.
Affinity Cross-Linking of '1I-bFGF. Confluent cultures (3-5 x 106 cells per 10-cm dish) were washed once with ice-cold PBS and once with BSA (2 mg/ml)/PBS. Cells pretreated with suramin were washed three additional times with ice-cold PBS to remove any trace of suramin, which might inhibit the binding of bFGF to its receptor. Cells were incubated for 2 hr at 4°C in DMEM containing BSA (2 mg/ml), 1 mM MgCl2, 0.1 ,uM KI, heparin (1 ,g/ml; Hepar, Franklin, OH), and 1251-bFGF (3 ng/ml, 150 ,Ci/mmol). The cells were washed once with ice-cold PBS containing heparin, (10 ,ug/ml), BSA (2 mg/ml), 0.1 AM KI, and 1 mM MgCl2 and then once with ice-cold PBS. 125I-bFGF was cross-linked by addition of 0.15 mM disuccinimidyl suberate (DSS), prepared from a 15 mM DSS stock solution in dimethyl sulfoxide, for 20 min at room temperature. To quench free-reactive DSS, a large excess of 10 mM Tris-HCI, pH 7.5/150 mM glycine was added for 5 min followed by a wash with ice-cold PBS. For SDS/PAGE analysis of FGFreceptor cross-linking, cells were scraped, centrifuged, and resuspended in 40-60 1.l of lysis buffer (50 mM Tris-HCl, pH 8.0/150 mM NaCl/0.5 mM MgCl2/0.5% Nonidet P-40) for 10 min at 40C. After clarification by centrifugation at maximum speed in an Eppendorf microcentrifuge, the supernatant fractions were diluted to adjust for cell number, mixed with SDS/PAGE sample buffer [100 mM Tris-HCI, pH 6.8/10mM EDTA/5% (wt/vol) SDS/10% (vol/vol) glycerol/50 mM dithiothreitol/0.05% bromphenol blue], boiled, and analyzed by SDS/PAGE using 0.75-mm-thick 6% polyacrylamide gels. For fluorography, the gels were fixed, dried, and exposed to Kodak X-Omat autoradiography film at -70'C. RESULTS
Autocrine Transformation by spbFGF and K-fgf. NIH 3T3 fibroblasts transfected by bFGF fused to a signal peptide were highly transformed in culture. Their rate of proliferation was markedly enhanced when compared to parental 3T3 cells, and their growth was density-independent ( Fig. 1) and anchorage-independent, as shown by their ability to grow on nonadhesive poly(HEMA)-coated dishes (see Fig. 3B ). Although NIH 3T3 cells transfected with native bFGF cDNA grew at an enhanced proliferation rate and to a higher saturation density, they were density-arrested and anchorage-dependent like parental 3T3 cells (Fig. 1) (22) .
Reversal of Autocrine Transformation of Suramin. Additional evidence for autocrine transformation in spbFGF cells was obtained by use of suramin, a polyanionic drug known to inhibit growth factor-receptor interactions and thereby inhibit autocrine transformation (23) (24) (25) . Suramin inhibited the mitogenic activity of bFGF on NIH 3T3 cells in a dosedependent manner (data not shown). At 0.4 mM, suramin reversed the transformed phenotype of spbFGF cells in terms of proliferation rate, morphology, and adhesion. Suramin inhibited the accelerated proliferation rate of spbFGF cells (Fig. 3A) and K-fgf cells (not shown) compared to that of parental 3T3 cells. On the other hand, suramin did not inhibit the proliferation rate of ras-transformed cells, but in fact enhanced it (Fig. 3A) , suggesting that suramin-sensitive growth factors do not play a major role in ras-mediated transformation. The inhibitory effect of suramin on spbFGF and K-fgf cell proliferation was completely reversible by either removing the drug or competing it with an excess of bFGF. Suramin also inhibited the ability of spbFGF cells to grow in an anchorage-independent manner on poly(HEMA)-coated dishes (Fig. 3B ).
Cells transfected with spbFGF underwent profound morphological alterations. Sparse spbFGF cells grew as single cells and at higher densities formed large cell aggregates. Under phase-contrast microscopy, spbFGF cells demonstrated a small, round, and refractile cell body with thin long cytoplasmic extensions (Fig. 4a) . In the presence of suramin, the cells attached, spread, and acquired a morphology similar to that of parental 3T3 cells (Fig. 4b) . At high density, cells that did not have room to attach and spread died in the presence of suramin. The same phenotypic reversal of transformation was observed with K-fgf cells (Fig. 4 c and d) . Removal fluorescent staining for actin (Fig. 4 g and h) . Suramin induced the reassembly of cytoskeletal actin filaments and focal adhesion points. Typical actin stress fibers were detected as early as 4 hr after addition of suramin and were prominent at 24 hr, when cells were spread maximally (Fig.  4h) . Suramin had no effect on the morphology of spbFGF and K-fgf-transformed cells when applied in the presence of cycloheximide, indicating that the effects of suramin are not posttranslational but require de (Fig. 6) . Time (3) . Further evidence for internal autocrine stimulation by v-sis is the lack of growth inhibition by neutralizing antibodies to PDGF (27) and reduced surface receptors for PDGF (25 spbFGF-transformed cells to disrupt an internal autocrine loop, and suramin uptake into endosomes has been demonstrated in v-sis-transformed cell lines (25) . On the other hand, suramin is a highly charged membrane-impermeable molecule (28 
